PSVT Management: Suboptimal Care Is Too Frequent
Brian P. Rose, PA-C, MPH, AACC
Applying Best Practices in the Diagnosis of PSVT
Jennifer Carlquist, PA-C
From Episode to Empowerment
Decoding IgA Nephropathy: From Suspicion to Solution
Jonathan Barratt, MD, PhD
Chee Kay Cheung, MBChB, MRCP, PhD
An De Vriese, MD, PhD
Jörg Latus, MD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Navigating KDIGO Guidance in IgAN
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Itching for Answers: Holistic CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
When Itching Hurts: Quality of Life Disruption in CKD-aP
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Reading Between the Lines: What PROMs Reveal About Itch
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Sayna Norouzi, MD
Extra Innings – Sustaining Victory Beyond the First Game
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Turning the Double Play – Comprehensive Secondary Prevention